INCEPTORBIO Trademark

Trademark Overview


On Monday, March 14, 2022, a trademark application was filed for INCEPTORBIO with the United States Patent and Trademark Office. The USPTO has given the INCEPTORBIO trademark a serial number of 97310330. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, September 30, 2024. This trademark is owned by Inceptor Bio, LLC. The INCEPTORBIO trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

biological preparations, namely, preparations for use in the treatment of cancer; biologic preparations for medical and therapeutic purposes for immunotherapy; biological preparations for immunotherapy, namely, T-Cell therapy; cells for medical or clinical use; pharmaceutical preparations and therapeutic agents for the treatment of cancer; medical diagnostic reagents for treatment of cancer

reagents for research purposes, drug discovery and development; Diagnostic reagents for clinical use for treatment of cancer
inceptorbio

General Information


Serial Number97310330
Word MarkINCEPTORBIO
Filing DateMonday, March 14, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, September 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 7, 2023

Trademark Statements


Description of MarkThe mark consists of a stylized circle made up of other stylized circles to the left of the stylized words InceptorBio.
Goods and Servicesbiological preparations, namely, preparations for use in the treatment of cancer; biologic preparations for medical and therapeutic purposes for immunotherapy; biological preparations for immunotherapy, namely, T-Cell therapy; cells for medical or clinical use; pharmaceutical preparations and therapeutic agents for the treatment of cancer; medical diagnostic reagents for treatment of cancer
Pseudo MarkINCEPTOR BIO
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Servicesreagents for research purposes, drug discovery and development; Diagnostic reagents for clinical use for treatment of cancer

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, February 2, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInceptor Bio, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMorrisville, NC 27560

Party NameInceptor Bio, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMorrisville, NC 27560

Trademark Events


Event DateEvent Description
Wednesday, December 28, 2022NON-FINAL ACTION WRITTEN
Thursday, March 17, 2022NEW APPLICATION ENTERED
Thursday, March 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 18, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, December 24, 2022ASSIGNED TO EXAMINER
Wednesday, December 28, 2022NON-FINAL ACTION E-MAILED
Wednesday, December 28, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 18, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 2, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, February 2, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, February 2, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 2, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, February 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 17, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 1, 2023TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, November 1, 2023DIVISIONAL REQUEST RECEIVED
Wednesday, November 1, 2023SOU EXTENSION 1 FILED
Wednesday, November 1, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 21, 2023DIVISIONAL PROCESSING COMPLETE
Tuesday, November 21, 2023SOU EXTENSION 1 GRANTED
Wednesday, November 22, 2023CORRECTED NOA E-MAILED
Wednesday, November 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 24, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 24, 2024SOU EXTENSION 2 FILED
Wednesday, April 24, 2024SOU EXTENSION 2 GRANTED
Monday, September 30, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 30, 2024SOU EXTENSION 3 GRANTED
Monday, September 30, 2024SOU EXTENSION 3 FILED
Thursday, April 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED